Gregory Reyes
Directeur/Membre du Conseil chez ARTELO BIOSCIENCES, INC.
Fortune : - $ au 30/04/2024
Provenance du réseau au premier degré de Gregory Reyes
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
62
| Public Company | Pharmaceuticals: Major | 62 |
| Public Company | Pharmaceuticals: Major | 12 | |
| Public Company | Pharmaceuticals: Major | 2 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Gregory Reyes via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
Biogen Idec, Inc. (North Carolina)
 Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen Idec, Inc. (North Carolina) is a pharmaceutical company based in Durham, NC. The company develops pharmaceutical products. Michel Pericles Vounatsos has been the CEO of the company since 2016. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member Chief Executive Officer Chief Executive Officer Chief Tech/Sci/R&D Officer Chief Operating Officer Corporate Officer/Principal | |
Biogen GmbH
 Biogen GmbH Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen GmbH is a pioneer in the field of neuroscience since 1978. The company is based in Ismaning, Germany. Biogen focuses on research in therapeutic areas with a strong emphasis on difficult-to-treat diseases. The German company was founded in 1978 by Charles Weissman, Kenneth Murray, Heinz Schaller, Phillip Sharp, Walter Gilbert. The CEO is Michel Pericles Vounatsos. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Director/Board Member Director/Board Member Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| Yale University | College/University | Undergraduate Degree Undergraduate Degree Doctorate Degree Doctorate Degree | |
| Massachusetts Institute of Technology | College/University | Corporate Officer/Principal Undergraduate Degree Undergraduate Degree Graduate Degree | |
| IRONWOOD PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member Director/Board Member | |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| VOYAGER THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer | |
| University of Pennsylvania | College/University | Undergraduate Degree Undergraduate Degree Graduate Degree | |
| Georgetown University | College/University | Masters Business Admin Director/Board Member Director/Board Member | |
Anadys Pharmaceuticals, Inc.
 Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ. | Pharmaceuticals: Major | Chairman Chairman Director/Board Member | |
| EDITAS MEDICINE, INC. | Biotechnology | Chief Executive Officer Director/Board Member Corporate Officer/Principal | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Masters Business Admin Doctorate Degree Director/Board Member | |
| University of California | College/University | Corporate Officer/Principal Corporate Officer/Principal Undergraduate Degree | |
Vicarius Pharma AG
 Vicarius Pharma AG Miscellaneous Commercial ServicesCommercial Services Vicarius Pharma AG provides research and development services for pharmaceutical, biotech, and medical companies. The private company is based in Zurich, Switzerland. The Swiss company was founded by Hans-Peter Hasler. | Miscellaneous Commercial Services | Chairman Founder Corporate Officer/Principal | |
| OVID THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member President Chief Operating Officer | |
| Harvard Medical School | College/University | Doctorate Degree Corporate Officer/Principal Graduate Degree | |
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Biogen MA, Inc.
 Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | Biotechnology | Human Resources Officer Corporate Officer/Principal Corporate Officer/Principal | |
| VERASTEM, INC. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Biotechnology | Chief Tech/Sci/R&D Officer Director/Board Member Director/Board Member | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Graduate Degree Undergraduate Degree Doctorate Degree | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Chairman Founder Chairman | |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel | |
| Biomedical Sciences Careers Program, Inc. | Corporate Officer/Principal Director/Board Member | ||
| DECIBEL THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer Chairman | |
| MOMENTA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| RADIUS HEALTH, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| SYNLOGIC, INC. | Biotechnology | General Counsel Chief Executive Officer | |
| Tufts University School of Medicine | College/University | Doctorate Degree Doctorate Degree | |
| SAVARA INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Stablix, Inc.
 Stablix, Inc. Miscellaneous Commercial ServicesCommercial Services Stablix, Inc. is a biotechnology company based in New York, NY. The company is focused on establishing a new paradigm for tackling diverse diseases by harnessing the power of the body's own cellular machinery through targeted protein stabilization. Stablix's restored™ platform generates heterobifunctional small molecules (restoracs™) that selectively recruit active deubiquitinases (dubs) to target proteins for precise removal of ubiquitin to restore protein function. The company is currently advancing its lead programs towards clinical studies. The company's platform is based on the work of Henry Colecraft, Ph.D., professor of physiology and cellular biophysics, and professor of pharmacology, Columbia University Irving Medical Center. Stablix was founded in June 2021 with a $63 million series A led by founding investor Versant Ventures with New Enterprise Associates (NEA), Cormorant Asset Management, Euclidean Capital, and Alexandria Venture Investments. Stuart Anthony Kingsley has been the CEO of the company since 2022. | Miscellaneous Commercial Services | Chief Executive Officer Director/Board Member | |
| THE MEDICINES COMPANY | Pharmaceuticals: Major | President Chairman | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
| VISTERRA INC | Pharmaceuticals: Major | General Counsel Director/Board Member | |
| Georgetown University Law Center | College/University | Graduate Degree Graduate Degree | |
| IDENIX PHARMACEUTICALS INC | Pharmaceuticals: Major | General Counsel Investor Relations Contact | |
| University of Georgia | College/University | Undergraduate Degree Doctorate Degree | |
| The Johns Hopkins University School of Medicine | College/University | Corporate Officer/Principal Doctorate Degree | |
| MORPHIC HOLDING, INC. | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal | |
| AGIOS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Director of Finance/CFO | |
| THERMO FISHER SCIENTIFIC | Medical Specialties | Director/Board Member Chief Executive Officer |
Statistiques
Internationale
| Etats-Unis | 47 |
| Allemagne | 2 |
| Suisse | 2 |
| Pays-Bas | 2 |
| Canada | 2 |
Sectorielle
| Health Technology | 31 |
| Consumer Services | 13 |
| Commercial Services | 5 |
| Finance | 3 |
| Consumer Durables | 2 |
Opérationnelle
| Director/Board Member | 303 |
| Corporate Officer/Principal | 215 |
| Independent Dir/Board Member | 91 |
| Undergraduate Degree | 66 |
| Chief Executive Officer | 51 |
Relations les plus connectées
| Insiders | |
|---|---|
| Eric Rowinsky | 36 |
| Marijn Dekkers | 35 |
| George Scangos | 33 |
| Hans-Peter Hasler | 28 |
| Steven Holtzman | 28 |
| Caroline Dorsa | 27 |
| Stephen Sherwin | 26 |
| Douglas Williams | 25 |
| Alexander Denner | 25 |
| Francesco Granata | 24 |
| Michael Lytton | 24 |
| Phillip Sharp | 20 |
| James Mullen | 19 |
| Richard Mulligan | 19 |
| Glenn F. Pierce | 17 |
- Bourse
- Insiders
- Gregory Reyes
- Connexions Sociétés